PMID: 16524539Mar 10, 2006Paper

Metabolic modulation of myocardial ischemia

Current Cardiology Reports
Sonal Jani, Steven R Bergmann

Abstract

The metabolic pathways of the heart during normoxia and ischemia have been well studied. High plasma fatty acid concentrations and the myocardial accumulation of long-chain fatty acyl metabolites during ischemia correlate with increased morbidity and mortality. However, enhanced glucose use can maintain cell homeostasis, diminish ischemic injury, and be clinically beneficial. Metabolic modulators represent a new class of drugs with the potential to treat myocardial ischemia. They are ideal as adjunctive anti-ischemic therapy because they lack the hemodynamic consequences of traditional therapy and treat the underlying metabolic dysfunction that leads to contractile failure and arrhythmias. Clinical studies have demonstrated their efficacy in acute and chronic settings. It is anticipated that there will be greater utilization of this new class of agents in the near future.

References

May 1, 1979·Neurology·P BoucheH P Cathala
Mar 1, 1989·The Journal of Clinical Investigation·P B CorrB E Sobel
Aug 1, 1981·The American Journal of Cardiology·H Vik-Mo, O D Mjøs
May 1, 1983·International Journal of Cardiology·H D White, J B Lowe
Mar 1, 1981·Progress in Cardiovascular Diseases·A J Liedtke
Mar 1, 1995·Journal of Cardiovascular Pharmacology·F M JeffreyC R Malloy
Jun 1, 1994·The Journal of Clinical Investigation·G BodenL Rossetti
Nov 4, 1998·Seminars in Nuclear Medicine·S R Bergmann
Jun 19, 2001·American Journal of Physiology. Heart and Circulatory Physiology·R RamasamyS R Bergmann
May 4, 2002·Heart Failure Reviews·William C Stanley, Margaret P Chandler
May 4, 2002·Heart Failure Reviews·Andrew A WolffRoberto Ferrari
Apr 2, 2003·Fundamental & Clinical Pharmacology·William C Stanley, Mario Marzilli
Sep 6, 2003·Journal of the American College of Cardiology·Iwan C C van der HorstUNKNOWN Zwolle Infarct Study Group
Jan 22, 2004·JAMA : the Journal of the American Medical Association·Bernard R ChaitmanUNKNOWN Combination Assessment of Ranolazine In Stable Angina (CARISA) Investigators
Apr 16, 2004·European Heart Journal·Leong LeeMichael Frenneaux
Apr 20, 2004·Journal of the American College of Cardiology·Bernard R ChaitmanUNKNOWN MARISA Investigators
Sep 18, 2004·Circulation Research·Janice M Huss, Daniel P Kelly
Jan 27, 2005·The American Journal of Cardiology·Michel F RousseauAndrew A Wolff
Jan 27, 2005·JAMA : the Journal of the American Medical Association·Shamir R MehtaUNKNOWN CREATE-ECLA Trial Group Investigators
Mar 31, 2005·European Heart Journal·Carl S Apstein, Lionel H Opie
Apr 7, 2005·Current Medical Research and Opinion·B Staels
Sep 27, 2005·Expert Review of Cardiovascular Therapy·William C Stanley
Jan 13, 2006·Circulation·Thomas ThomUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee

❮ Previous
Next ❯

Citations

Jan 18, 2011·Current Cardiology Reports·Kenneth N Giedd, Steven R Bergmann
Apr 16, 2020·JPEN. Journal of Parenteral and Enteral Nutrition·Dorothee WeihrauchMatthias L Riess
Apr 2, 2017·Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology·Michele M SalzmanMatthias L Riess

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Related Papers

Journal of Cardiovascular Pharmacology and Therapeutics
U Thadani
Journal of Cardiovascular Pharmacology and Therapeutics
Bramah N Singh, Nitin Wadhani
Journal of Molecular and Cellular Cardiology
Heather FraserAlexander S Clanachan
© 2021 Meta ULC. All rights reserved